Page last updated: 2024-08-17

adenosine diphosphate and Kidney Failure

adenosine diphosphate has been researched along with Kidney Failure in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, JS	1
Alam, M; Bobek, J; Delarosa, A; Dokainish, H; Gonzalez, R; Lakkis, N	1
Belch, JJ; Henderson, IS; Stewart, WK; Taylor, JE	1
Fiore, L; Hasbargen, JA; Kaufman, JS; O'Connor, TZ; Perdriset, G	1

Reviews

1 review(s) available for adenosine diphosphate and Kidney Failure

Article	Year
Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018, Volume: 18, Issue:6 Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Administration, Oral; Aging; Blood Platelets; Cyclooxygenase 1; Diabetes Mellitus; Drug Administration Schedule; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Receptor, PAR-1; Receptors, Purinergic P2Y12; Renal Insufficiency; Risk Factors; Secondary Prevention; Thrombin; Thromboxane A2; Time Factors; Vascular Diseases	2018

Article

Year

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018, Volume: 18, Issue:6

Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Administration, Oral; Aging; Blood Platelets; Cyclooxygenase 1; Diabetes Mellitus; Drug Administration Schedule; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Receptor, PAR-1; Receptors, Purinergic P2Y12; Renal Insufficiency; Risk Factors; Secondary Prevention; Thrombin; Thromboxane A2; Time Factors; Vascular Diseases

2018

Other Studies

3 other study(ies) available for adenosine diphosphate and Kidney Failure

Article	Year
In vitro inhibition of platelet aggregation in response to increasing concentrations of tirofiban in patients with significant renal insufficiency. The American heart hospital journal, 2009,Summer, Volume: 7, Issue:1 Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Chi-Square Distribution; Creatinine; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet-Rich Plasma; Renal Insufficiency; Risk Factors; Tirofiban; Tyrosine	2009
Erythropoietin does not increase whole-blood platelet aggregation in vitro. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:5 Topics: Adenosine Diphosphate; Blood Platelets; Collagen; Erythropoietin; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Count; Renal Dialysis; Renal Insufficiency	1994
A pharmacodynamic study of clopidogrel in chronic hemodialysis patients. Journal of thrombosis and thrombolysis, 2000, Volume: 10, Issue:2 Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Chronic Disease; Clopidogrel; Dose-Response Relationship, Drug; Hemostasis; Humans; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Renal Dialysis; Renal Insufficiency; Thrombosis; Ticlopidine	2000